AAAAAA

   
Results: 1-15 |
Results: 15

Authors: SPAPEN H ZHANG HB DEMANET C VLEMINCKX W VINCENT JL HUYGHENS L
Citation: H. Spapen et al., DOES N-ACETYL-L-CYSTEINE INFLUENCE CYTOKINE RESPONSE DURING EARLY HUMAN SEPTIC SHOCK, Chest, 113(6), 1998, pp. 1616-1624

Authors: TENBOSCH JEV DEMANET C BALDUCK N BAKKUS MHC DERAEVE H DESPRECHINS B OTTEN J THIELEMANS K
Citation: Jev. Tenbosch et al., THE USE OF THE ANTI-MALARIA DRUG FANSIDAR(R) (PYRIMETHAMINE AND SULFADOXINE) IN THE TREATMENT OF A PATIENT WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME AND FAS DEFICIENCY, British Journal of Haematology, 102(2), 1998, pp. 578-581

Authors: DEJONGE J HEIRMAN C DEVEERMAN M VANMEIRVENNE S DEMANET C BRISSINCK J THIELEMENS K
Citation: J. Dejonge et al., BISPECIFIC ANTIBODY TREATMENT OF MURINE B-CELL LYMPHOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 162-165

Authors: HAUTEKEETE ML HORSMANS Y VANWAEYENBERGE C DEMANET C HUBENS H HENRION J VERBIST L BORGERS P BRENARD R MICHIELSEN P VERSIECK J ADLER M YAO SH RAHIER J GEUBEL AP
Citation: Ml. Hautekeete et al., AMOXICILLIN-CLAVULANATE-INDUCED HEPATITIS IS LINKED TO THE DR-BETA-1-ASTERISK-1501 DR-BETA-5-ASTERISK-0101-DQ-BETA-1-ASTERISK-0602 HAPLOTYPE/, Hepatology, 26(4), 1997, pp. 86-86

Authors: THONNARD J GERVAIS T HEUSTERSPREUTE M MERSCH G DECANCK I DEGREEF C DEMANET C VANWAEYENBERGE C
Citation: J. Thonnard et al., A NEW SILENT MUTATION AT CODON-35 IN EXON-2 YIELDING DRB1-ASTERISK-04012 ALLELE, Tissue antigens, 49(3), 1997, pp. 274-276

Authors: SCHOTS R DEMANET C VANRIET I LACOR P DEWAELE M VANCAMP B
Citation: R. Schots et al., PATTERNS OF CRP AND CYTOKINE RELEASE IN VENOOCCLUSIVE LIVER-DISEASE AND ENDOTHELIAL LEAKAGE SYNDROME AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1641-1641

Authors: DEMANET C BRISSINCK J DEJONGE J THIELEMANS K
Citation: C. Demanet et al., BISPECIFIC ANTIBODY-MEDIATED IMMUNOTHERAPY OF THE BCL(1) LYMPHOMA - INCREASED EFFICACY WITH MULTIPLE INJECTIONS AND CD28-INDUCED COSTIMULATION, Blood, 87(10), 1996, pp. 4390-4398

Authors: DECANCK I DEMANET C MERSCH G JANNES G ROMBOUT A ROSSAU R VANWAEYENBERGE C
Citation: I. Decanck et al., CHARACTERIZATION OF A NEW DRB4 ALLELE (DRB4-ASTERISK-0104), Tissue antigens, 48(3), 1996, pp. 213-216

Authors: SCHOTS R VERBRUGGEN LA DEMANET C
Citation: R. Schots et al., G-CSF IN FELTYS-SYNDROME - CORRECTION OF NEUTROPENIA AND EFFECTS ON CYTOKINE RELEASE, Clinical rheumatology, 14(1), 1995, pp. 116-118

Authors: FOULON W VANLIEDEKERKE D DEMANET C DECATTE L DEWAELE M NAESSENS A
Citation: W. Foulon et al., MARKERS OF INFECTION AND THEIR RELATIONSHIP TO PRETERM DELIVERY, American journal of perinatology, 12(3), 1995, pp. 208-211

Authors: DEJONGE J BRISSINCK J HEIRMAN C DEMANET C LEO O MOSER M THIELEMANS K
Citation: J. Dejonge et al., PRODUCTION AND CHARACTERIZATION OF BISPECIFIC SINGLE-CHAIN ANTIBODY FRAGMENTS, Molecular immunology, 32(17-18), 1995, pp. 1405-1412

Authors: BRUYLAND M LISSENS W DEWAELE M DEMANET C
Citation: M. Bruyland et al., HYPO-IGG IN MYOTONIC-DYSTROPHY IS DUE TO A SELECTIVE REDUCTION OF THEIGG1-SUBCLASS SERUM LEVEL, Muscle & nerve, 17(10), 1994, pp. 1233-1234

Authors: FLAMAND V SORNASSE T THIELEMANS K DEMANET C BAKKUS H BAZIN H TIELEMANS F LEO O URBAIN J MOSER M
Citation: V. Flamand et al., MURINE DENDRITIC CELLS PULSED IN-VITRO WITH TUMOR-ANTIGEN INDUCE TUMOR RESISTANCE IN-VIVO, European Journal of Immunology, 24(3), 1994, pp. 605-610

Authors: DEMANET C BRISSINCK J LEE O MOSER M THIELEMANS K
Citation: C. Demanet et al., ROLE OF T-CELL SUBSETS IN THE BISPECIFIC ANTIBODY (ANTIIDIOTYPE X ANTI-CD3) TREATMENT OF THE BCL(1) LYMPHOMA, Cancer research, 54(11), 1994, pp. 2973-2978

Authors: VANRIET I DEGREEF C DELFAVERO H DEMANET C VANCAMP B
Citation: I. Vanriet et al., PRODUCTION OF FIBRONECTIN AND ADHERENCE TO FIBRONECTIN BY HUMAN MYELOMA CELL-LINES, British Journal of Haematology, 87(2), 1994, pp. 258-265
Risultati: 1-15 |